Community-Acquired Pneumonia: all 325 studies
Page 3 of 4. Open to participants first (78), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of XueBiJing in Patients With SepsisCompletedNCT03475732Not applicable
- KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAPCompletedNCT03474991Phase 3
- Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired PneumoniaCompletedNCT03452826Not applicable
- Early Mobilization of Patients With Community-acquired PneumoniaCompletedNCT03426813Not applicable
- Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency MedicineCompletedNCT03411824
- Innate Immune Response During Community Acquired PneumoniaTerminatedNCT03379207
- DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired PneumoniaTerminatedNCT03360851Not applicable
- Description of Pneumococcal PneumoniaCompletedNCT03322670
- Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"CompletedNCT03315403
- Reason Evaluation of Initial Treatment Failure in Patients With CAPStatus unknownNCT03280004
- A Sputum Screening Test to Rule-out Pneumonia at an Early StageCompletedNCT03256604
- Trial of Respiratory Infections in Children for Enhanced DiagnosticsCompletedNCT03233516
- CRP and Thoracic Emergency Ultrasound in PneumoniaCompletedNCT03212248
- Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.TerminatedNCT03208361Phase 3
- Biomarker Guided Antibiotic Treatment in Community-Acquired PneumoniaStatus unknownNCT03146182Not applicable
- Clinical Characteristics and Microbiology of Community-Acquired PneumoniaStatus unknownNCT03098914
- A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired PneumoniaCompletedNCT02963142
- Smoking Cessation Intervention in Respiratory InpatientsCompletedNCT02922387Phase 4
- Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired PneumoniaStatus unknownNCT02913118Phase 4
- Pathogen Detection and Community Acquired PneumoniaCompletedNCT02880384Not applicable
- Avoidable Readmissions For Patients Hospitalized With Community-Acquired PneumoniaCompletedNCT02833259
- Study of Progression of Community Acquired Pneumonia in the HospitalCompletedNCT02782013
- Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired PneumoniaStatus unknownNCT02775968
- Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAPCompletedNCT02668237Not applicable
- Increasing Community-acquired Pneumonia Protocol Adherence by Antibiotic StewardshipCompletedNCT02604628Not applicable
- Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in OutpatientsStatus unknownNCT02600806Phase 4
- Proton Pump Inhibitors and Risk of Community-acquired PneumoniaCompletedNCT02555852
- Corticosteroid Therapy for Severe Community-Acquired PneumoniaStatus unknownNCT02552342Phase 4
- Use of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired PneumoniaCompletedNCT02523885
- Community-Acquired Pneumonia : Evaluation of CorticosteroidsCompletedNCT02517489Phase 3
- A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of ChinaStatus unknownNCT02492425
- A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China)Status unknownNCT02489578
- HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract InfectionsCompletedNCT02454114Not applicable
- Potential Role for Echocardiography in Adult Patients With Community-Acquired PneumoniaCompletedNCT02441855
- Clinical Practice Guidelines and Impact of Audit and Feedback in the Emergency DepartmentCompletedNCT02427048Not applicable
- Short-course Antimicrobial Therapy for Paediatric Respiratory InfectionsCompletedNCT02380352Phase 4
- Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With PneumoniaCompletedNCT02276092
- A P3 Comparator Trial in Community Acquired Bacterial PneumoniaWithdrawnNCT02269644Phase 3
- Improving Antibiotic Use in Hospitalized Patients With PneumoniaCompletedNCT02264756
- Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in HospitalsStatus unknownNCT02224716
- A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAPCompletedNCT02205112Phase 3
- The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe PneumoniaStatus unknownNCT02203110
- Clinical Pediatric Pneumonia Score in Critically Ill ChildrenWithdrawnNCT02139384
- Lung Ultrasound in Pleuritic Chest PainCompletedNCT02107001
- Pharmacokinetics of Levofloxacin in Intensive Care UnitCompletedNCT02018081Phase 4
- Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)CompletedNCT01964495Not applicable
- Short Duration Treatment of Non-severe Community Acquired PneumoniaStatus unknownNCT01963442Phase 2
- Standardized Emergency Care for Community Acquired Pneumonia (CAP)CompletedNCT01963000
- A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial PneumoniaStatus unknownNCT01937832Phase 3
- A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial PneumoniaCompletedNCT01886053Phase 2
- Targeting Platelet-Leukocyte Aggregates in Pneumonia With TicagrelorCompletedNCT01883869Phase 1
- MACCE in Hospitalized Patients With Community-acquired PneumoniaStatus unknownNCT01773863
- Santeon-CAP; Dexamethasone in Community-acquired PneumoniaTerminatedNCT01743755Phase 4
- Reducing Cost of Azythromycin by Transferring From IV to Oral TherapyWithdrawnNCT01741909Not applicable
- Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired PneumoniaCompletedNCT01723644Not applicable
- Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.CompletedNCT01683487
- Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial PneumoniaWithdrawnNCT01666743Phase 4
- Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAPWithdrawnNCT01662258Not applicable
- Suitability of Antibiotic Treatment for CAPCompletedNCT01661920Not applicable
- Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract InfectionsCompletedNCT01660204Not applicable
- Effect of Simvastatin on Pneumonia Prognosis in Elderly PatientsStatus unknownNCT01651728Phase 3
- Corticosteroids in Community-acquired PneumoniaWithdrawnNCT01631916Not applicable
- Chest CT-scan for the Diagnosis of Community-acquired PneumoniaCompletedNCT01574066Not applicable
- Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.CompletedNCT01564771
- Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysCompletedNCT01561885Not applicable
- A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial PneumoniaCompletedNCT01561794Phase 3
- Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)CompletedNCT01537250Phase 2
- Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)CompletedNCT01530763Phase 2/3
- Duration of Antibiotic Therapy in Community - Acquired PneumoniaStatus unknownNCT01492387Phase 4
- Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAPCompletedNCT01420744Phase 2
- Causes and Outcomes of Community Acquired PneumoniaCompletedNCT01336036
- Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin InfectionsCompletedNCT01293435
- Impact of a Multidimensional Intervention in Elderly Patients With PneumoniaCompletedNCT01285869Not applicable
- The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in BeijingStatus unknownNCT01236677
- Corticosteroids in Community Acquired PneumoneaCompletedNCT01228110Not applicable
- Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe PneumoniaCompletedNCT01200706Phase 4
- Procoagulant Activity in Patients With Community Acquired Pneumonia, Pleural Effusion and EmpyemaCompletedNCT01178580
- Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumoniaCompletedNCT01166932Phase 4
- Failure and Cardiovascular Events in Community-acquired PneumoniaCompletedNCT01143155
- Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired PneumoniaCompletedNCT01086397
- Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired PneumoniaTerminatedNCT01081964Phase 2
- Sleep Apnea Syndrome and Community Acquired PneumoniaCompletedNCT01071421
- Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired PneumoniaWithdrawnNCT01018199Not applicable
- CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized PatientsCompletedNCT00987792
- Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP TrialCompletedNCT00973154Phase 3
- Impact of Statins on Cytokine Expression in PneumoniaWithdrawnNCT00946166Phase 4
- A Global Active Surveillance for Community Acquired PneumoniaCompletedNCT00929721Not applicable
- Corticoids in Severe Community-Acquired Pneumonia (CAP)CompletedNCT00908713Phase 4
- Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired PneumoniaTerminatedNCT00887276Phase 4
- A Polymerase Chain Reaction (PCR) - Based Method to Improve Antibiotic Prescribing for PneumoniaWithdrawnNCT00867841
- Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired PneumoniaCompletedNCT00818610Phase 4
- Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)CompletedNCT00812084
- Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction CatheterCompletedNCT00763620Not applicable
- Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration FactorsStatus unknownNCT00752947Phase 4
- A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired PneumoniaCompletedNCT00717561Phase 3
- Avelox for Treatment of Elderly Patients With Community Acquired PneumoniaCompletedNCT00665327Phase 4
- Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired PneumoniaCompletedNCT00653172Phase 2
- Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural EffusionCompletedNCT00646490
- Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired PneumoniaCompletedNCT00638859Phase 3
- Ketek in CAP / AECB in Ambulatory Adult PatientsCompletedNCT00546676Phase 4